GeNeuro SA: End of the Liquidity Contract With GILBERT DUPONT
11 7월 2024 - 1:00AM
Business Wire
Regulatory News:
GeNeuro SA (Paris:GNRO) and GILBERT DUPONT have terminated the
liquidity contract entered into on March 6, 2021.
This termination took effect on June 30, 2024, after market
closing.
On that date of 30 June 2024 post market closing, the following
assets appeared on the liquidity contract:
- Number of shares: 93,539
- Cash balance of the liquidity account: € 91,665.80
As a reminder, as of 29 December 2023, the following resources
were booked to the liquidity account:
- Number of shares: 118,739
- Cash balance of the liquidity account: € 48,977.59
It is also reminded that at the initial implementation of the
contract, the following resources were included in the liquidity
account:
- Number of shares: nil
- Cash: € 750,000.00
Following the closure of the liquidity contract, the securities
and cash were transferred to the Company.
For more information, please visit the website :
www.geneuro.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240710735859/en/
GeNeuro
Jesús Martin-Garcia
Président et directeur général +41 22 552 4800
investors@geneuro.com
NewCap (France)
Louis-Victor Delouvrier (investors)
+33 1 44 71 98 52 Arthur Rouillé (médias) +33 1 44 71 94 98
geneuro@newcap.eu
GeNeuro (EU:GNRO)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
GeNeuro (EU:GNRO)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024